Male Sprague-Dawley rats, 7-12 weeks old, were killed by cervical dislocation and decapitated, and their brains were rapidly removed. After the cerebellum, which is devoid of receptor activity (2), was excised, each brain was homogenized in 10 ml of 0.05 M Tris HCl buffer, pH 7.4 at 350, by .10 strokes of a motor-driven ground-glass pestle, and the homogenate was diluted to 110 volumes of tissue with cold Tris buffer.
The elegant conceptualization of Goldstein et al. (1) that opiate-receptor binding should be stereospecific enabled us to demonstrate and quantify opiate-receptor binding (2) . Specific-receptor binding of opiates and their antagonists closely parallels their pharmacological potency and is confined to nervous tissue. The present report describes the kinetics of specific opiate-receptor binding and the influences of temperature, pH, ionic concentrations, and several opiates and their antagonists.
MATERIALS AND METHODS
Male Sprague-Dawley rats, 7-12 weeks old, were killed by cervical dislocation and decapitated, and their brains were rapidly removed. After the cerebellum, which is devoid of receptor activity (2) , was excised, each brain was homogenized in 10 ml of 0.05 M Tris HCl buffer, pH 7.4 at 350, by .10 strokes of a motor-driven ground-glass pestle, and the homogenate was diluted to 110 volumes of tissue with cold Tris buffer.
In the standard binding assay, 1.9-ml aliquots of this freshly prepared homogenate were incubated for 5 min in triplicate with either levorphanol or dextrorphan (0.1 gM). After cooling to 40, [3H]naloxone was added to a final concentration of 8 nM (65,000 cpm) and incubation at 350 in a final volume of 2 ml was resumed for 15 min. Samples were cooled to 40 in an ice bath and then filtered under reduced pressure through Whatman glass-fiber circles (GF-B) which were chosen because of their ability to hold relatively large quantities of tissue while maintaining an adequate flow rate. Filters were washed twice with 8 ml of cold Tris buffer. The entire filtration cycle consumed only 20 sec for each sample. The filters were shaken with 1 ml of 10% sodium dodecyl sulfate in counting vials for 30 min. After the addition of 12 ml of PCS (Amersham-Searle; Phase Combining System), radioactivity was determined by liquid-scintillation spectrometry, at a counting efficiency of 28%. Protein was measured by the method of Lowry et al. (3) , with bovine-serum albumin as a standard.
(-)-Naloxone was labeled by tritium exchange at the New England Nuclear Corp. 50 mg of naloxone were dissolved in 0.3 ml of trifluoroacetic acid with 50 mg of 5% Rh/A1203 to which were added 25 Ci of 3H20, and the mixture was incubated 18 hr at 800. In our laboratory, a 70-mCi portion of [3H]naloxone was evaporated twice to dryness, and purified by thin-layer chromatography on Silica gel G plates (MNKieselgel G/uv 254) of 0.25-mm thickness (n-butanol-glacial acetic acid-H20; 4:1:2). When the purified [3H]naloxone was chromatographed in three additional solvent systems, the resulting single peak of radioactivity coincided with authentic naloxone, which was chromatographed beside it. The specific activity of [3H]naloxone was 6.1 Ci/mmol of standard, as determined by comparison with the ultraviolet absorption of standard solutions of naloxone at 260 nm. Based upon this specific activity determination and a counting efficiency of 28%, 378 cpm is equivalent to 0.1 pmol of naloxone. 
RESULTS
The time-course of [3H naloxone binding to whole rat-brain homogenates was studied at 350 in the presence of 0.1 uM levorphanol or 0.1 uM dextrorphan (Fig. 1) . For most opiates, analgesic activity is highly stereospecific with almost all activity residing in isomers with a configuration analogous to that of D-(-)-morphine. Levorphanol is a potent opiate with the D-configuration, while dextrophan is its enantiomer and is essentially devoid of analgesic activity.
Binding of [3H]naloxone occurred rapidly, was linear for no more than 1 min, and plateaued between 10 and 30 min so that equilibrium was reached by 15 min (Fig. 1) In all subsequent experiments, incubations with 0.1 ,M concentrations each of levorphanol and dextrorphan were included and the radioactivity in the presence of levorphanol was subtracted as a "blank" value representing nonspecific binding, while the failure of dextrorphan to reduce binding ensured that the effect of levophanol was related to its affinity for the specific opiate receptor. In a typical experiment in which 65,000 cpm of [3H]naloxone (8 nM) were incubated in 2 ml with brain homogenate (18 mg wet weight equal to 1.8 mg of protein) 2000 cpm and 800 cpm were bound, respectively, in the absence and presence of 0.1 MM levorphanol.
In the absence of tissue about 300 cpm were bound to the filters. Accordingly, only about 500 cpm were bound nonspecifically to brain tissue in the presence of levorphanol so that the ratio of specific to nonspecific binding in typical experiments would be about 3. Henceforth, "specific receptor (Fig. 2) . Specific binding displayed a sharp pH optimum at 7.4 ( Fig. 2) , with a steep decline at more acid pH values and a gradual decline at more alkaline pH values. In some experiments, the fall in binding at slightly acid pH was less sharp, presumably because of variable tissue aggregation.
The thermal stability of the opiate receptor was examined by prior incubation of the tissue for 10 min at various tem-' peratures and then conducting the standard binding assay at 35°. Binding was not affected by prior incubation at temperatures from 20 to 400, but was reduced by heating at higher temperatures. Heating for 10 min at temperatures in excess of 500 reduced specific naloxone binding by 90% or more (Fig. 2) (Fig. 3) . The divalent cations calcium and magnesium lowered binding by about 40% at concentrations of 3 mM and further lowered binding to 30% of control values at 10 mM. In the absence of added sodium and potassium, specific binding was the same as in. the presence of physiological concentrations of these ions. At concentrations in excess of 500 mM both lithium and sodium produced a gradual decrease of binding. Potassium, which at physiological concentrations of 5 mM did not affect binding, reduced specific binding 20% at 10 mM and 50% at 30 mM. Sodium, lithium, magnesium, and calcium did not alter the nonspecific binding of [3HInaloxone in the presence of nonradioactive levorphanol.
Naloxone binding was demonstrated to be saturable by two techniques (Fig. 4) (Fig. 5) . Specific binding is a timedependent process, whereas nonspecific binding in the presence of nonradioactive levorphanol was maximal even at incubation periods of 1 min (Fig. 1) . From the data on the rate of binding, it was possible to calculate the bimolecular rate constant of opiate-receptor association, Ki, which is equal to [2. The rate constant at 250 for [3H]naloxone dissociation from the receptor (K2) was calculated to be 1.61 4 .24 X 10-2 sec -'. The calculated value of K2/K, based upon these direct kinetic data was 14.0 4-4.1 nM, which corresponds to the experimentally determined concentration of 16 nM naloxone required for half-maximal saturation of receptor binding (Fig. 4) .
We compared the affinity of various drugs for opiate-receptor binding by incubating several concentrations of nonradioactive drugs with tissue homogenate before the addition of [3H]naloxone. The concentration of drug that lowered specific binding of 8 nM [3H]naloxone by 50% was estimated (Table 1) by log-probit analysis (Fig. 6) . For the 15 opiaterelated drugs examined, the slopes of lines describing percent inhibition against drug concentration were all parallel. The pharmacologic potencies of opiates and opiate antagonists were related proportionally to their ability to compete with Values represent means from 3 log-probit determinations each using five concentrations of drug. though in both cases the antagonist had twice the affinity of the agonist.
Codeine, which is analgesically about 1/10 as potent as morphine, displayed less than 1/3000 the receptor affinity of morphine. Because codeine is O-demethylated by liver microsomal enzymes to morphine, it may exert analgesic activity only after metabolism to morphine (6) (7) (8) .
Propoxyphene, which is a weak analgesic (9) (11) . The moderate analgesic activity of codeine despite its negligible affinity for the opiate receptor may be explained by its conversion in vivo to morphine.
Our data support suggestions that opiates and their antagonists compete for the same receptor sites (12, 13 In our previous study (2) , and recent experiments (unpublished observations) we demonstrated the presence of the opiate receptor in mouse, bovine, guinea pig, cat, chick, monkey, toad, and fish brain as well as rat brain, indicating a broad phylogenetic distribution.
Physiological concentrations of calcium significantly inhibit and the chelating agents EDTA, EGTA, and citrate enhance receptor binding (manuscript in preparation), suggesting that endogenous calcium plays a role in the action of opiates (15) . The opiate receptor is extremely sensitive to digestion by trypsin and chymotrypsin as well as detergents such as Triton X-100, sodium dodecylsulfate, and deoxycholate (manuscript in preparation).
The number of opiate receptors increases in the brains of mice as early as 2 hr after implantation of a morphine pellet, and declines when pellets are removed in parallel with the fall in physical dependence (manuscript in preparation).
Other workers have studied the binding of opiates to brain tissue but failed to show specificity and pharmacologic relevance (16 
